Join to view full profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-4673
Dr. Haley is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1976 - 1979
University of Texas Southwestern Medical SchoolClass of 1976
Certifications & Licensure
TX State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2008 Apr 23
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
Publications & Presentations
PubMed
- Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer.Ronald G Hall 2nd, Shuhan Liu, Manjunath P Pai, William C Putnam, Indhumathy Subramaniyan
Journal of Oncology Pharmacy Practice. 2026-07-01 - 10 citationsRace, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien
JAMA Network Open. 2023-12-01 - 20 citationsSafety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf
NPJ Breast Cancer. 2022-12-01
Journal Articles
- Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the in Vitro Integrity of T-cells from Cancer PatientsKevin Courtney, Yull Arriaga, Barbara Haley, John C Mansour, Ponciano D Cruz, David Harker, Farshid Araghizadeh, Clinical Cancer Research
Press Mentions
Drugs Reprogram Genes in Breast Tumors to Prevent Endocrine ResistanceMay 14th, 2019
Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
